CW
Highly rated in
34
conditions
Highly rated in
34
conditions
Check Dr. Chester B. Whitley's experience treating your condition:
About Dr. Chester B. Whitley

Chester Whitley is a Pediatrics specialist and a Medical Genetics expert in Minneapolis, Minnesota. Whitley has been practicing medicine for over 43 years and is highly rated in 34 conditions, according to our data. His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Gangliosidosis, and GM1 Gangliosidosis. He is licensed to treat patients in Minnesota. Whitley is currently accepting new patients.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 15 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Chester B. Whitley it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Chester B. Whitley accepts the following insurance:

  •  Ambetter
  •  Medica
  •  HealthPartners
Locations
2450 Riverside Ave, Minneapolis, MN 55455
Other Locations
2512 S 7th St, Floor 3, Minneapolis, MN 55454
909 Fulton St Se, Suite 2-201, Minneapolis, MN 55455
500 Se Harvard St, Minneapolis, MN 55455
Background & Education
Graduate Institution
University Of Minnesota Medical School, 1980
Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Genetics in MN
Hospital Affiliations
M Health Fairview Southdale Hospital
M Health Fairview University Of Minnesota Medical Center - West Bank Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

A Natural History Study of the Gangliosidoses
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)
MPS VI Clinical Surveillance Program (CSP)
A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)
View 12 Less Clinical Trials -

101 Total Publications

Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors